Whilst we have seen the COVID pandemic wreak havoc on care pathways across the country, it has also spurred closer and...
Whilst we have seen the COVID pandemic wreak havoc on care pathways across the country, it has also spurred closer and...
This month’s PharmaTimes is packed with a variety of features centred on clinical research, the lifeblood of our...
This month we celebrate women from various factions of healthcare who are all striving to achieve better outcomes for...
With the anchor now securely lodged in 2021, what’s on the horizon for the life sciences industry and for healthcare...
This month PharmaTimes presents Alantra’s annual ranking of the fastest growing pharma companies in the UK, and again...
Despite entering another national lockdown, we begin this year with a great deal more hope for a return to ‘normality’...
2020 will undoubtedly go down in history as being the year the world as we know it was crushed by a new coronavirus,...
Our cover feature this month (p19) highlights pharma’s laudable ability to continually innovate in the logistics...
In this month’s issue of PharmaTimes we take a closer look at plans for the NHS Reset, which essentially aims to embed...
Welcome to the patient-centricity special! Articles in this issue shine a light on how pharma is making strides in...
The future is diversity. That is the central, take-home message of our cover feature this month on diversity and...
As part of our theme of celebrating positives in pharma and health during this difficult and turbulent time, while...
COVID-19 will rightfully continue to dominate the news and our thoughts over the course of the pandemic and beyond,...
As the impact of the global COVID-19 pandemic hits hard and fast, PharmaTimes is open for business as usual and our...
It’s really heartening to see that the UK’s smaller, privately owned pharma sector continues to thrive in an operating...